Q3 FY2025 · Press release
Zymeworks Presents Initial Clinical Data from the Phase 1 trial of ZW191, an Antibody-Drug Conjugate Targeting Folate Receptor-⺠at AACR-NCI-EORTC Conference · October 23, 2025 · 3 pages
Read Zymeworks Inc.'s results firsthand
Preview the first 2 pages of this press release
Create a free account to start reading
Full documents are included with Professional